![Joanne Donovan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 350 175 $ in data 30/09/2026
Joanne M.
Donovan is currently Chief Medical Officer at Edgewise Therapeutics, Inc. since 2021.
Formerly, Dr. Donovan was Medical Director at GelTex Pharmaceuticals, Inc., Chief Medical Officer & SVP-Clinical Development at Astria Therapeutics, Inc. from 2011 to 2021, Associate Clinical Professor at Harvard Medical School, and Vice President-Clinical Development at Genzyme Corp.
from 1998 to 2011.
Education includes undergraduate, graduate, and doctorate degrees from Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 13/08/2026 | 8.625 ( 0,01% ) | 350 175 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 27/04/2021 |
| Società | Posizione | Fine |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 23/04/2021 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Direttore Tecnico/Scientifico/R&S | 01/07/2011 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
GelTex Pharmaceuticals, Inc.
 GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Direttore Tecnico/Scientifico/R&S | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Astria Therapeutics, Inc.
 Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for allergic & immunologic diseases | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edgewise Therapeutics, Inc.
 Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
